Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Reset all filters
01 2Sanofi
02 3GSK
03 2Pfizer Inc
04 4SANOFI VACCINES CANADA LTD.
Reset all filters
01 1KIT
02 2POWDER FOR SOLUTION
03 1Powder And Solvent For Injection Solution
04 4SOLUTION
05 1SUSPENSION
06 2VAC
Reset all filters
01 2Originator
02 8Schedule D
03 1Withdrawn
Reset all filters
01 1Acwy Vax - Powder And Solvent For
02 4MENQUADFI
03 2MENVEO
04 2Menactra
05 1NEISVAC-C
06 1NIMENRIX
Reset all filters
01 8Canada
02 1Malta
03 2South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Group A Meningococcal Polysaccharide
Brand Name : Menactra
Dosage Form : VAC
Dosage Strength : 4ug/0.5ml
Packaging : 0.5X1ug/0.5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Group C Meningococcal Polysaccharide
Brand Name : Menactra
Dosage Form : VAC
Dosage Strength : 4ug/0.5ml
Packaging : 0.5X1ug/0.5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Withdrawn
Registration Country : Malta
Neisseria Meningitidis Polysaccharide Group C; Neisseria Meningitidis Polysaccharide Group C; Meningococcal Polysaccharide Group W-135
Brand Name : Acwy Vax - Powder And Solvent For
Dosage Form : Powder And Solvent For Injection Solution
Dosage Strength : 50MCG; 50MCG
Packaging :
Approval Date : 2008-09-30
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL GROUP A OLIGOSACCHARIDE
Brand Name : MENVEO
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2347393
Regulatory Info : Schedule D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
Brand Name : MENVEO
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 5MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2347393
Regulatory Info : Schedule D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL POLYSACCHARIDE VACCINE GRP C
Brand Name : NEISVAC-C
Dosage Form : SUSPENSION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML/10X0.5ML/20X0.5ML
Approval Date :
Application Number : 2245057
Regulatory Info : Schedule D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
Brand Name : NIMENRIX
Dosage Form : KIT
Dosage Strength : 5MCG/0.5ML
Packaging : 0.5ML/10X0.5ML
Approval Date :
Application Number : 2402904
Regulatory Info : Schedule D
Registration Country : Canada

Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : Schedule D
Registration Country : Canada

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : Schedule D
Registration Country : Canada

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : Schedule D
Registration Country : Canada

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Schedule D
Registration Country : Canada
MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : Schedule D
Registration Country : Canada

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF